BFS
MIRM icon

Bare Financial Services’s Mirum Pharmaceuticals MIRM Stock Holding History

Bare Financial Services’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.62K Buy
50
+21
+72% +$1.98K ﹤0.01% 688
2025
Q4 		$2.29K Buy
29
+7
+32% +$502 ﹤0.01% 816
2025
Q3 		$1.61K Buy
22
+10
+83% +$636 ﹤0.01% 872
2025
Q2 		$611 Buy
+12
New +$534 ﹤0.01% 1065

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Bare Financial Services's MIRM Position: Q1 2026 in Review

Bare Financial Services increased its Mirum Pharmaceuticals (MIRM) stake by 72% in Q1 2026, buying an estimated $1.98K and bringing the position to 50 shares worth $4.62K. The position accounts for ﹤0.01% of the portfolio, ranked #688.

Bare Financial Services first reported a position in MIRM in Q2 2025 and has held it in 4 quarters since. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Bare Financial Services held 50 shares of Mirum Pharmaceuticals worth $4.62K as of Q1 2026.
  • Bare Financial Services bought 21 Mirum Pharmaceuticals shares in Q1 2026, an estimated $1.98K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Bare Financial Services's portfolio in Q1 2026, its #688 holding.
  • Bare Financial Services first reported a position in Mirum Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Bare Financial Services's 13F filing for Q1 2026, filed 14 May 2026.